Owner Novartis AG

Inventors Imase, Hidetomo; Yasoshima, Kayo; Yamada, Ken; Kawanami, Toshio; Ohmori, Osamu; Miyake, Takahiro; Mogi, Muneto

Agent Davies Collison Cave

Pub. Number AU-A-2012203815

Parent 2008333272

Filing date 28 June 2012

Wipo publication date 19 July 2012

C07D 207/14 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 3/06 Drugs for disorders of the metabolism

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms